← FDA Drug Approvals (Drugs@FDA)

VALSARTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON · Approved 2025-06-05

Drug application

FDA Application #

ANDA216460

Application type

Abbreviated New Drug Application (Generic)

Brand name

VALSARTAN

Generic name

VALSARTAN ORAL

Active ingredients

VALSARTAN

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

RUBICON

Manufacturer

Advagen Pharma Ltd

First approval

2025-06-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown